Tsh Biopharmoration (Taiwan) Technical Analysis

8432 Stock  TWD 61.00  0.30  0.49%   
As of the 23rd of December, Tsh Biopharmoration has the Coefficient Of Variation of 1641.15, semi deviation of 1.36, and Risk Adjusted Performance of 0.0536. Tsh Biopharmoration technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate tsh biopharmoration mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if Tsh Biopharmoration is priced more or less accurately, providing market reflects its prevalent price of 61.0 per share.

Tsh Biopharmoration Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Tsh, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Tsh
  
Tsh Biopharmoration's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Tsh Biopharmoration technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Tsh Biopharmoration technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tsh Biopharmoration trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

tsh biopharmoration Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of tsh biopharmoration volatility. High ATR values indicate high volatility, and low values indicate low volatility.

tsh biopharmoration Trend Analysis

Use this graph to draw trend lines for tsh biopharmoration. You can use it to identify possible trend reversals for Tsh Biopharmoration as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Tsh Biopharmoration price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Tsh Biopharmoration Best Fit Change Line

The following chart estimates an ordinary least squares regression model for tsh biopharmoration applied against its price change over selected period. The best fit line has a slop of   0.01  , which means tsh biopharmoration will continue generating value for investors. It has 122 observation points and a regression sum of squares at 8.27, which is the sum of squared deviations for the predicted Tsh Biopharmoration price change compared to its average price change.

About Tsh Biopharmoration Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of tsh biopharmoration on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of tsh biopharmoration based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on tsh biopharmoration price pattern first instead of the macroeconomic environment surrounding tsh biopharmoration. By analyzing Tsh Biopharmoration's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Tsh Biopharmoration's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Tsh Biopharmoration specific price patterns or momentum indicators. Please read more on our technical analysis page.

Tsh Biopharmoration December 23, 2024 Technical Indicators

Most technical analysis of Tsh help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tsh from various momentum indicators to cycle indicators. When you analyze Tsh charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for Tsh Stock Analysis

When running Tsh Biopharmoration's price analysis, check to measure Tsh Biopharmoration's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tsh Biopharmoration is operating at the current time. Most of Tsh Biopharmoration's value examination focuses on studying past and present price action to predict the probability of Tsh Biopharmoration's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tsh Biopharmoration's price. Additionally, you may evaluate how the addition of Tsh Biopharmoration to your portfolios can decrease your overall portfolio volatility.